Oncogenic MLL-fusion proteins often hijack essential molecular mechanisms during leukemogenesis. The histone methyltransferase SETD2 was implicated in the regulation of transcription, DNA damage and other cellular processes. Recent studies identified a critical role for SETD2 in MLL-rearranged leukemia. These results may help to unravel important functions of SETD2 in hematopoiesis.
CITATION STYLE
Skucha, A., Ebner, J., & Grebien, F. (2018). SETD2 in MLL-rearranged leukemia–a complex case. Molecular and Cellular Oncology, 5(4). https://doi.org/10.1080/23723556.2018.1503492
Mendeley helps you to discover research relevant for your work.